---
{"dg-publish":true,"permalink":"/the-collaterals/indications/venous-thromboembolism/"}
---

# venous thromboembolism (VTE)
---

> [!info] definition
> umbrella term used to describe [[deep venous thrombosis\|deep vein thrombosis]] with or without [[pulmonary embolism\|pulmonary embolism]]

### epidemiology


### etiology
any factor that causes [[hypercoagulability\|hypercoagulability]], endothelial damage, or [[venous stasis\|venous stasis]] can cause VTE (aka **[[virchow triad\|virchow triad]]**)

> [!tip] virchow triad
> 1. **hypercoagulability**: increased platelet adhesion, thrombophilia (e.g. factor V leiden mutation), use of oral contraceptives, pregnancy
> 2. **endothelial damage**: inflammatory or traumatic vessel injuries can lead to activation of clotting factors through contact with exposed subendothelial collagen
> 3. **venous stasis**: varicosis, external pressure on the extremity, immobilization (e.g. hospitalization, bed rest, long flights or bus rides), local application of heat (induces venous dilation, slowing of flow)

#### transient risk factors
- surgical factors
	- surgery under general anesthesia
	- cesarean delivery
- **immobilization**
	- acute illness requiring complete bed rest
	- lower extremity injury with restricted mobility for â‰¥ 3 days
	- long-distance travel
- estrogen-related factors
	- pregnancy
	- use of OCPs or HRT
- intravascular devices
	- indwelling venous catheter
	- implanted pacemaker or cardiac defibrillator leads
- patient factors
	- obesity
	- smoking
	- IV drug use
	- nonadherence to VTE prophylaxis

#### chronic risk factors
- patient factors
	- age > 60 years
	- personal or family history DVT or PE
- prothombotic chronic illnesses
	- **active cancer**: gastric, pancreatic, pulmonary, hynecological, and urologic tumors in particular are associated with an increase risk for DVT because these types of tumors produce proteins and cytokines with thrombophilic effects
	- [[nephrotic syndrome\|nephrotic syndrome]]
	- autoimmune disorders
	- hereditary thrombophilia
		- **[[factor v leiden\|factor v leiden]]**
		- [[antithrombin iii deficiency\|antithrombin iii deficiency]], [[protein c deficiency\|protein c deficiency]], [[protein s deficiency\|protein s deficiency]]
		- prothrombin mutation

### pathophysiology
**[[virchow triad\|virchow triad]]**
- **hypercoagulability**: increased platelet adhesion, thrombophilia, use of oral contraceptives, pregnancy
- **endothelial damage**: inflammatory/traumatic vessel injuries â€“> activation of clotting factors through contact with exposed subendothelial collagen
- **venous stasis**: varicosis, external pressure on the extremity, immobilization, local application of heat

![[deep venous thrombosis#clinical features\|deep venous thrombosis#clinical features]]

### evaluation



![[deep venous thrombosis#ddx\|deep venous thrombosis#ddx]]

### management


### prevention
VTE prophylaxis refers to the primary prevention of DVT or PE in at-risk individuals, and includes general preventive measures, mechanical VTE prophylaxis, and pharmacoloical VTE prophylaxis
It should be chosen based on presence of risk factors for VTE and estimated risk of bleeding on anticoagulation therapy
- general preventive measures
	- regular exercise
	- early postoperative mobilization
	- physiotherapy
	- avoid certain medications (e.g. OCPs)
- pharmacologic prophylaxis
- mechanical prophylaxis

#### duration of prophylaxis in hospitalized patients
- mechanical: until patient is mobile
- pharmacological: 
	- seriously ill medical patients: **at least 7 days** (extend to span duration of hospitalization)
	- surgical patients: consider extended therapy for **> 3 weeks**
		- based on type of surgery, degree of restricted mobility, etc



### subtypes and variants
- phlegmasia alba dolens
- [[phlegmasia cerulea dolens\|phlegmasia cerulea dolens]]
- [[paget-schroetter disease\|paget-schroetter disease]] (upper extremity dvt)

### complications
- [[pulmonary embolism\|pulmonary embolism]]
- [[post-thrombotic syndrome\|postthrombotic syndrome]]
- [[venous gangrene\|venous gangrene]] (rare complication)


---


> [!note]- info
> system:: 
> specialty:: 
> rapidReview:: [[the collaterals/indications/venous thromboembolism#clinical features\|ðŸ«]], [[the collaterals/indications/venous thromboembolism#evaluation\|ðŸ”¬]], [[the collaterals/indications/venous thromboembolism#management\|ðŸª„]]

> [!abstract]- references
> -  




